Apremilast in psoriasis – a prospective real‐world study

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-3083|32|2|254-259

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.32, Iss.2, 2018-02, pp. : 254-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival rates of biological therapies for psoriasis treatment in real‐world clinical practice: A Canadian multicentre retrospective study

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 59, Iss. 1, 2018-02 ,pp. : e11-e14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real‐world Canadian dermatology clinics: a multicenter retrospective study

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 1, 2018-01 ,pp. : e32-e34

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting

By Bergenstal Richard M.   Garrison Louis P.   Wintle Matthew   Blickensderfer Amy   Wade Rolin   Hou Likun   Miller Lesley-Ann   Scism-Bacon Jamie   Zagar Anthony   Misurski Derek   Herman William H.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 531-540

Informa Healthcare

Access to resources Recommend Favorite

Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting

By Bergenstal Richard M.   Garrison Louis P.   Miller Lesley-Ann   Hou Likun   Blickensderfer Amy   Zagar Anthony   Stanley Shelley   Bhargava Anuj   Wade Rolin   Herman William H.  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2335-2342

Informa Healthcare

Access to resources Recommend Favorite

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

By Gottlieb A. B.   Strober B.   Krueger J. G.   Rohane P.   Zeldis J. B.   Hu C. C.   Kipnis C.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1529-1538

Informa Healthcare

Access to resources Recommend Favorite